Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

16DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: (r)-azasetron besylate, Uxp39eq477, 2025360-91-0, 2h-1,4-benzoxazine-8-carboxamide, n-(3r)-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, benzenesulfonate (1:1), Arazasetron besylate, Unii-uxp39eq477

Molecular Formula

C₂₃H₂₆ClN₃O₆S

Molecular Weight

508.0 g/mol

InChI Key

GFVBDLIBPSGFDL-ZOWNYOTGSA-N

FDA UNII

UXP39EQ477

1 2D Structure

R-Azasetron Besylate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide;benzenesulfonic acid

2.1.2 InChI

InChI=1S/C17H20ClN3O3.C6H6O3S/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21;7-10(8,9)6-4-2-1-3-5-6/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23);1-5H,(H,7,8,9)/t13-;/m0./s1

2.1.3 InChI Key

GFVBDLIBPSGFDL-ZOWNYOTGSA-N

2.1.4 Canonical SMILES

CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4.C1=CC=C(C=C1)S(=O)(=O)O

2.1.5 Isomeric SMILES

CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)N[C@H]3CN4CCC3CC4.C1=CC=C(C=C1)S(=O)(=O)O

2.2 Other Identifiers

2.2.1 UNII

UXP39EQ477

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Sens-401

2.3.2 Depositor-Supplied Synonyms

1. (r)-azasetron Besylate

2. Uxp39eq477

3. 2025360-91-0

4. 2h-1,4-benzoxazine-8-carboxamide, N-(3r)-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, Benzenesulfonate (1:1)

5. Arazasetron Besylate

6. Unii-uxp39eq477

2.4 Create Date

2017-11-26

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₂₆ClN₃O₆S
Molecular Weight	508.0 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	3
Exact Mass	507.1230844 g/mol
Monoisotopic Mass	507.1230844 g/mol
Topological Polar Surface Area	125 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	707
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2